Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
Acquired by Sun Pharmaceutical Industries
|
| gptkbp:employees |
over 1,000
|
| gptkbp:founded |
1950
|
| gptkbp:founder |
Dr. H. A. Taro
|
| gptkbp:headquarters |
gptkb:Hawthorne,_New_York
|
| https://www.w3.org/2000/01/rdf-schema#label |
Taro Pharmaceuticals
|
| gptkbp:market |
gptkb:Israel
gptkb:North_America |
| gptkbp:parent_company |
gptkb:Sun_Pharmaceutical_Industries
|
| gptkbp:products |
generic pharmaceuticals
|
| gptkbp:specialization |
cardiology
neurology oncology antibiotics psychiatry dermatology antidepressants pain management urology gastroenterology |
| gptkbp:website |
www.taro.com
|
| gptkbp:bfsParent |
gptkb:Trelstar_LA
gptkb:Eligard_22.5_mg gptkb:Eligard_30_mg gptkb:Eligard_45_mg gptkb:Eligard_7.5_mg |
| gptkbp:bfsLayer |
7
|